Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVVD Invivyd, Inc.

盘后交易 05-18 17:14:23 EDT

1.13

-0.08

-6.61%

盘后1.16

+0.03+2.67%

17:13 EDT

最高1.23	最低1.12	成交量345.52万
今开1.21	昨收1.21	日振幅9.09%
总市值3.33亿	流通市值2.31亿	总股本2.95亿
成交额400.22万	换手率1.69%	流通股本2.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":1.13,"timestamp":1779134400000,"preClose":1.21,"halted":0,"volume":3455192,"hourTrading":{"tag":"盘后","latestPrice":1.1602,"preClose":1.13,"latestTime":"17:13 EDT","volume":71353,"amount":81322.3198599,"timestamp":1779138815001,"change":0.0302,"changeRate":0.026726,"amplitude":0.053097},"delay":0,"changeRate":-0.0661157024793389,"floatShares":204000000,"shares":295000000,"eps":-0.353273,"marketStatus":"盘后交易","change":-0.08,"latestTime":"05-18 17:14:23 EDT","open":1.21,"high":1.23,"low":1.12,"amount":4002188.6283079996,"amplitude":0.090909,"askPrice":1.23,"askSize":1500,"bidPrice":1.16,"bidSize":9720,"shortable":3,"etf":0,"ttmEps":-0.353273,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1779148800000},"marketStatusCode":4,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":1.21,"preHourTrading":{"tag":"盘前","latestPrice":1.23,"preClose":1.21,"latestTime":"09:19 EDT","volume":17939,"amount":22057.378215200002,"timestamp":1779110387333,"change":0.02,"changeRate":0.016529,"amplitude":0.064298},"postHourTrading":{"tag":"盘后","latestPrice":1.1602,"preClose":1.13,"latestTime":"17:13 EDT","volume":71353,"amount":81322.3198599,"timestamp":1779138815001,"change":0.0302,"changeRate":0.026726,"amplitude":0.053097},"volumeRatio":0.700714,"impliedVol":1.0749,"impliedVolPercentile":0.4382},"requestUrl":"/m/hq/s/IVVD","defaultTab":"news","newsList":[{"id":"1152037603","title":"Invivyd与合作者发表新论文，评估新冠单克隆抗体早期耐受性并与疫苗接种结果对比","url":"https://stock-news.laohu8.com/highlight/detail?id=1152037603","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152037603?lang=zh_cn&edition=full","pubTime":"2026-05-11 19:02","pubTimestamp":1778497361,"startTime":"0","endTime":"0","summary":"Invivyd, Inc. 与其合作者共同撰写了一篇新的研究论文，该论文重点评估了针对新冠病毒的单克隆抗体疗法的早期耐受性情况。研究团队将所获得的临床数据与现有新冠疫苗接种后观察到的不良反应结果进行了系统性比较分析。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183344206","title":"Invivyd公布Revolution项目进展 推进潜在首创及最优麻疹单抗候选药物Vms063用于治疗与预防","url":"https://stock-news.laohu8.com/highlight/detail?id=1183344206","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183344206?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:04","pubTimestamp":1775732653,"startTime":"0","endTime":"0","summary":"生物技术公司Invivyd, Inc.宣布，其Revolution项目取得重要进展，正加速推进新型麻疹单克隆抗体候选药物Vms063的研发。该药物具备成为同类首创及最优疗法的潜力，旨在用于麻疹的治疗与预防。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110360648","title":"Invivyd公布2025年第四季度及全年财报，披露近期业务进展与Declaration临床试验更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1110360648","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110360648?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:05","pubTimestamp":1772712305,"startTime":"0","endTime":"0","summary":"Invivyd, Inc.近日发布了2025年第四季度及全年的财务业绩报告，同时公布了公司近期的业务发展动态以及Declaration临床试验项目的最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609516039","title":"Invivyd, Inc.盘中异动 股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609516039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609516039?lang=zh_cn&edition=full","pubTime":"2026-02-07 01:54","pubTimestamp":1770400492,"startTime":"0","endTime":"0","summary":"北京时间2026年02月07日01时54分，Invivyd, Inc.股票出现波动，股价大幅下跌5.56%。截至发稿，该股报1.62美元/股，成交量350.453万股，换手率1.24%，振幅9.94%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207015452a4858f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260207015452a4858f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198810666","title":"Invivyd与美国FDA就Liberty三期试验达成一致，将评估VYD2311抗体对比mRNA新冠疫苗安全性并探索抗体与疫苗联合使用的安全性与免疫学特征","url":"https://stock-news.laohu8.com/highlight/detail?id=1198810666","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198810666?lang=zh_cn&edition=full","pubTime":"2026-02-03 20:02","pubTimestamp":1770120135,"startTime":"0","endTime":"0","summary":"Invivyd公司已与美国食品药品监督管理局就Liberty三期临床试验方案达成共识。该试验旨在评估其研发的VYD2311抗体药物与mRNA新冠疫苗在安全性方面的对比数据，同时系统研究抗体与疫苗联合给药时的安全性和免疫学反应特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603866899","title":"Invivyd, Inc.盘中异动 早盘股价大跌5.10%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603866899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603866899?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:25","pubTimestamp":1768321550,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日00时25分，Invivyd, Inc.股票出现异动，股价大幅下挫5.10%。截至发稿，该股报2.33美元/股，成交量109.826万股，换手率0.39%，振幅8.56%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114002550a4bf9ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114002550a4bf9ab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601768888","title":"Invivyd, Inc.盘中异动 股价大跌5.10%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601768888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601768888?lang=zh_cn&edition=full","pubTime":"2026-01-07 01:42","pubTimestamp":1767721342,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日01时42分，Invivyd, Inc.股票出现波动，股价快速下挫5.10%。截至发稿，该股报2.42美元/股，成交量102.915万股，换手率0.37%，振幅6.47%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107014223a6fb3dea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107014223a6fb3dea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601421869","title":"Invivyd, Inc.盘中异动 早盘股价大跌5.20%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601421869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601421869?lang=zh_cn&edition=full","pubTime":"2026-01-05 23:34","pubTimestamp":1767627266,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日23时34分，Invivyd, Inc.股票出现异动，股价大幅跳水5.20%。截至发稿，该股报2.37美元/股，成交量86.8487万股，换手率0.31%，振幅6.80%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为1.88%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105233426953c056c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105233426953c056c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161114265","title":"Invivyd宣布启动Declaration临床试验，这是针对Vyd2311的第三阶段安慰剂对照关键研究，一种用于预防Covid的疫苗替代抗体","url":"https://stock-news.laohu8.com/highlight/detail?id=1161114265","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161114265?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:03","pubTimestamp":1766491396,"startTime":"0","endTime":"0","summary":"Invivyd宣布启动Declaration临床试验，这是针对Vyd2311的第三阶段安慰剂对照关键研究，一种用于预防Covid的疫苗替代抗体","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586089304","title":"Invivyd, Inc.盘中异动 急速跳水5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586089304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586089304?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:30","pubTimestamp":1764081051,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日22时30分，Invivyd, Inc.股票出现异动，股价大幅下挫5.42%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Pharmacyte  Biotech, Inc.、Anavex Life Sciences Corp.涨幅较大，Clearmind Medicine Inc.、Lunai Bioworks Inc.、Pasithea Therapeutics Corp.较为活跃，换手率分别为204.03%、126.16%、18.79%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、Anavex Life Sciences Corp.、Cardio Diagnostics Holdings Inc.，振幅分别为12.15%、7.95%、6.92%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223051a4b9b074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223051a4b9b074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134589274","title":"Invivyd宣布选定潜在的一流RSV抗体候选药物Vby329；目标为2026年下半年IND准备就绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1134589274","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134589274?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985764,"startTime":"0","endTime":"0","summary":"Invivyd宣布选定潜在的一流RSV抗体候选药物Vby329；目标为2026年下半年IND准备就绪","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191384298","title":"Invivyd 第三季度每股收益为 -0.06 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191384298","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191384298?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571449,"startTime":"0","endTime":"0","summary":"11月6日 - Invivyd 第三季度收入为 1312.9 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518271809","title":"Invivyd, Inc.盘中异动 早盘快速跳水5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518271809?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:09","pubTimestamp":1741619349,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时09分，Invivyd, Inc.股票出现波动，股价大幅下挫5.59%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3551.71%、926.79%、795.06%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230909a26a4960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230909a26a4960&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517161369","title":"Invivyd, Inc.盘中异动 快速跳水5.86%报0.998美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161369?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:00","pubTimestamp":1741273241,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时00分，Invivyd, Inc.股票出现波动，股价快速跳水5.86%。截至发稿，该股报0.998美元/股，成交量26.2609万股，换手率0.22%，振幅2.83%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230042963c5360&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230042963c5360&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948823","title":"Invivyd, Inc.盘中异动 股价大涨6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948823?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:36","pubTimestamp":1741185399,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时36分，Invivyd, Inc.股票出现异动，股价大幅拉升6.67%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为390.41%、261.05%、190.80%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Invivyd, Inc.，振幅分别为23.90%、20.71%、13.32%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223639963add94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223639963add94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516305677","title":"Invivyd, Inc.盘中异动 早盘急速跳水9.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516305677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516305677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098916,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分，Invivyd, Inc.股票出现异动，股价大幅跳水9.11%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1076.47%、1070.68%、423.99%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、12.01%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516989bad0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516989bad0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514332074","title":"Invivyd, Inc.盘中异动 早盘股价大跌7.21%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332074?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753116,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Invivyd, Inc.股票出现异动，股价大幅跳水7.21%。截至发稿，该股报1.15美元/股，成交量11.3726万股，换手率0.10%，振幅1.60%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514338978","title":"Invivyd, Inc.盘中异动 大幅拉升5.28%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514338978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514338978?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:11","pubTimestamp":1740669110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时11分，Invivyd, Inc.股票出现波动，股价快速上涨5.28%。截至发稿，该股报1.30美元/股，成交量44.3116万股，换手率0.37%，振幅8.13%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231150989518cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231150989518cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856912","title":"Invivyd, Inc.盘中异动 股价大跌5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856912?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:36","pubTimestamp":1740580583,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时36分，Invivyd, Inc.股票出现异动，股价快速下跌5.77%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262236239631501b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262236239631501b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514909720","title":"Invivyd, Inc.盘中异动 早盘股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514909720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514909720?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:35","pubTimestamp":1740494121,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时35分，Invivyd, Inc.股票出现波动，股价急速上涨5.55%。Invivyd, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Adial Pharmaceuticals, Inc、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为766.29%、489.24%、253.20%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Moleculin Biotech, Inc.、Silexion Therapeutics Corp，振幅分别为20.51%、15.89%、14.67%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223521962ff366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223521962ff366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.invivyd.com","stockEarnings":[{"period":"1week","weight":-0.1933},{"period":"1month","weight":-0.2924},{"period":"3month","weight":-0.2244},{"period":"6month","weight":-0.4851},{"period":"1year","weight":0.7188},{"period":"ytd","weight":-0.5101}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Invivyd, Inc.于2020年6月3日在特拉华州成立。该公司是一家处于商业阶段的公司，其使命是快速、永久地提供基于抗体的疗法，以保护脆弱人群免受流行病毒威胁的破坏性后果，从SARS-CoV-2开始。该公司专有的INVYMAB平台方法将最先进的病毒监测和预测建模与先进的抗体工程相结合。INVYMAB旨在促进快速、连续产生新的单克隆抗体（“MAB”），以跟上不断演变的病毒威胁。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.046272},{"month":2,"riseRate":0.2,"avgChangeRate":0.346603},{"month":3,"riseRate":0.2,"avgChangeRate":-0.241584},{"month":4,"riseRate":0.4,"avgChangeRate":-0.167616},{"month":5,"riseRate":0.6,"avgChangeRate":0.16962},{"month":6,"riseRate":0.25,"avgChangeRate":-0.236507},{"month":7,"riseRate":0.75,"avgChangeRate":0.147422},{"month":8,"riseRate":0.75,"avgChangeRate":0.158597},{"month":9,"riseRate":0.6,"avgChangeRate":0.03577},{"month":10,"riseRate":0.4,"avgChangeRate":0.071726},{"month":11,"riseRate":0.4,"avgChangeRate":0.062538},{"month":12,"riseRate":0.4,"avgChangeRate":0.008789}],"exchange":"NASDAQ","name":"Invivyd, Inc.","nameEN":"Invivyd, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Invivyd, Inc.,IVVD,Invivyd, Inc.股票,Invivyd, Inc.股票老虎,Invivyd, Inc.股票老虎国际,Invivyd, Inc.行情,Invivyd, Inc.股票行情,Invivyd, Inc.股价,Invivyd, Inc.股市,Invivyd, Inc.股票价格,Invivyd, Inc.股票交易,Invivyd, Inc.股票购买,Invivyd, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Invivyd, Inc.(IVVD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Invivyd, Inc.(IVVD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}